Skip to Main Content

Paper Details

Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay.
0
2023
Cancers, HER, HER-low cancers, HER2, HER2 mRNA, cancer, estrogen, estrogen receptor, mRNA, patients
Author NameAffiliation
Lajos PusztaiYale School of Medicine, Yale Cancer Center
  • 1 - 1

Datasets

Release 1.2